Summary, audience Q&A, panel discussion and closing of session

Back

Open Access

Summary, audience Q&A, panel discussion and closing of session

Session: What is the role of TTR in transthyretin amyloid cardiomyopathy?

Topic: Cardiomyopathies

Speaker: Doctor M. Maurer (New York, US) Professor T. Damy (Creteil, FR) Doctor J. Gillmore (Greater London, GB)

About the speakers

Doctor Mathew Maurer

Columbia University Irving Medical Centre, New York (United States of America)

15 presentations

4 followers

Professor Thibaud Damy

University Hospital Henri Mondor, Creteil (France)

37 presentations

1 follower

Doctor Julian Gillmore

UCL, Greater London (United Kingdom of Great Britain & Northern Ireland)

12 presentations

3 followers

5 more presentations in this session

Introduction

Speaker: Doctor M. Maurer (New York, US)

Access

Slides

Video

The role of TTR in ATTR-CM disease and treatment

Speaker: Professor T. Damy (Creteil, FR)

Access

Slides

Video

Question & answers

Access

The role of TTR as a surrogate marker in treatment of ATTR-CM

Speaker: Doctor J. Gillmore (Greater London, GB)

Access

Slides

Video

Questions & answers

Access

Access the full session

What is the role of TTR in transthyretin amyloid cardiomyopathy?

Speakers: Doctor M. Maurer, Professor T. Damy, Doctor J. Gillmore, Doctor M. Maurer, Professor T. Damy...

Access

Video

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources